Jayandra Jung Himali
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Jayandra Jung Himali has a total of 1000 co-authors. Here are the top co-authors by number of shared publications:
- Sudha Seshadri
Boston University and National Heart, Lung, and Blood Institute’s Framingham Study, MA (A.B., A.S.B., E.J.B., R.S.V., S.S.).
19 shared publications - Alexa S. Beiser
Boston University School of Public Health
13 shared publications Sudha Seshadri
Glenn Biggs Institute for Alzheimer and Neurodegenerative Diseases, The University of Texas Health Science Center at San Antonio, San Antonio, TX, USA
11 shared publications- Matthew Paul Pase
School of Psychological Sciences and Turner Institute for Brain and Mental Health, Monash University, Melbourne, Australia
10 shared publications - Charles DeCarli
Department of Neurology, University of California, Davis
9 shared publications - Mohammad Arfan Ikram
Erasmus MC University Medical Center, Rotterdam, The Netherlands
8 shared publications
Latest Publications
- Open Access
- 1 September 2026
- Published by Wolters Kluwer Health in Neurology Open Access
- Vol. 2 (3) , e000128
Sex-Specific Machine Learning–Enabled Risk Prediction for Dementia Using Cardiovascular Risk Factors
Background and ObjectivesDementia remains without curative treatments, underscoring the need for early identification of high-risk individuals. There may be sex-specific differences in associations...
- 1 September 2026
- Published by Wolters Kluwer Health in Neurology Open Access
- Vol. 2 (3) , e000128
Open AccessSex-Specific Machine Learning–Enabled Risk Prediction for Dementia Using Cardiovascular Risk Factors
Background and ObjectivesDementia remains without curative treatments, underscoring the need for early identification of high-risk individuals. There may be sex-specific differences in associations...
- 25 August 2026
- Published by Wolters Kluwer Health in Neurology
- Vol. 107 (4) , e218182
Association of Sleep Variables With Cognitive Performance and the Risk of Dementia in the Sleep and Dementia Consortium
Background and ObjectivesSleep is multidimensional, and it remains unclear which aspects are most relevant to cognition and dementia risk. We aimed to apply a data-driven approach to identify clust...
- 25 August 2026
- Published by Wolters Kluwer Health in Neurology
- Vol. 107 (4) , e218182
Association of Sleep Variables With Cognitive Performance and the Risk of Dementia in the Sleep and Dementia Consortium
Background and ObjectivesSleep is multidimensional, and it remains unclear which aspects are most relevant to cognition and dementia risk. We aimed to apply a data-driven approach to identify clust...
- Open Access
- 1 August 2026
- Published by Wolters Kluwer Health in Neurology Genetics
- Vol. 12 (4) , e200417
The Association Between APOE Genotype, Race, and Dementia
Background and ObjectivesThe apolipoprotein E (APOE) haplotypes are known to be associated with dementia, with the ε4 haplotype associated with higher risk. It has been suggested that the APOE ε2 a...
- 1 August 2026
- Published by Wolters Kluwer Health in Neurology Genetics
- Vol. 12 (4) , e200417
Open AccessThe Association Between APOE Genotype, Race, and Dementia
Background and ObjectivesThe apolipoprotein E (APOE) haplotypes are known to be associated with dementia, with the ε4 haplotype associated with higher risk. It has been suggested that the APOE ε2 a...
- 14 April 2026
- Published by Wolters Kluwer Health in Neurology
- Vol. 106 (7) , e214773
Association of an Aquaporin-4 Haplotype With Cognition, Brain Volume, and Dementia Risk in Community-Dwelling Individuals Without Dementia
Background and ObjectivesThe aquaporin-4 (AQP4) water channel plays an integral role in clearing brain waste. However, little is known about whether variations in the AQP4 gene contributes to brain...
- 14 April 2026
- Published by Wolters Kluwer Health in Neurology
- Vol. 106 (7) , e214773
Association of an Aquaporin-4 Haplotype With Cognition, Brain Volume, and Dementia Risk in Community-Dwelling Individuals Without Dementia
Background and ObjectivesThe aquaporin-4 (AQP4) water channel plays an integral role in clearing brain waste. However, little is known about whether variations in the AQP4 gene contributes to brain...
- Open Access
- 20 January 2026
- Published by SAGE Publications in Journal of Alzheimer’s Disease
- Vol. 109 (3) , 1142-1148
Hearing loss in the young-old is associated with increased risk for Alzheimer's disease and vascular dementia
Hearing loss is a risk factor for dementia, but dementia subtypes underlying this association and effect modifiers are unknown. Using data collected from 2000 Framingham Heart Study participants we found that hearing loss increases risk for Alzheimer's disease and vascular dementia in participants aged 60–70 years (“young-old”) at time of hearing assessment (Alzheimer's disease: HR 1.46[CI 1.07–2.0] p = 0.017; vascular dementia: HR 2.08[CI 1.22–3.56] p = 0.007). Longer duration of hearing loss determines increased risk for Alzheimer's disease and vascular dementia, and screening and intervention for hearing loss from mid-life may help reduce dementia.
- 20 January 2026
- Published by SAGE Publications in Journal of Alzheimer’s Disease
- Vol. 109 (3) , 1142-1148
Open AccessHearing loss in the young-old is associated with increased risk for Alzheimer's disease and vascular dementia
Hearing loss is a risk factor for dementia, but dementia subtypes underlying this association and effect modifiers are unknown. Using data collected from 2000 Framingham Heart Study participants we found that hearing loss increases risk for Alzheimer's disease and vascular dementia in participants aged 60–70 years (“young-old”) at time of hearing assessment (Alzheimer's disease: HR 1.46[CI 1.07–2.0] p = 0.017; vascular dementia: HR 2.08[CI 1.22–3.56] p = 0.007). Longer duration of hearing loss determines increased risk for Alzheimer's disease and vascular dementia, and screening and intervention for hearing loss from mid-life may help reduce dementia.
- Open Access
Lifelong trajectories of modifiable vascular risk factors and relation to cerebral small vessel disease in the Framingham Heart Study
Background: Cerebral small vessel disease (CSVD) is strongly linked to stroke and dementia risk, frequently predating clinical events for years to decades. Preventive efforts focus on treatment of modifiable vascular risk factors (VRF), but the complex changes in VRF over long periods in relation to CSVD burden remain unclear. Thus, we aimed to characterize life-long VRF trajectories in community-dwelling individuals and relate them to CSVD burden. Methods: Framingham Heart Study participants from the Original and Offspring cohorts with six or more repeated VRF assessments over their lifetime were eligible for the present study. Among those who underwent MRI imaging, CSVD burden was quantified by assigning one point each for cerebral microbleeds, covert infarcts, extensive white matter hyperintensities, cortical superficial siderosis, and high perivascular space burden (range: 0–5). VRF trajectories and trajectory-based clusters were then examined in relation to CSVD burden using functional regression analysis. Results: Of 7,961 participants with longitudinal VRF measurements (mean baseline age 39.8 ± 10 years, 45% men), 1,625 underwent MRI imaging after exclusions for other neurological conditions. In models that used individual VRF trajectories as covariates, systolic and diastolic blood pressure, pulse pressure, cigarettes per day and triglycerides were significantly associated with CSVD burden later in life. In a complementary analysis, we clustered VRF trajectories and then used each participant’s cluster assignment (rather than the raw trajectories) as the covariate; cluster assignments diverged early in life for systolic blood pressure and pulse pressure and were significantly associated with CSVD burden. Conclusions: Individuals following high risk lifetime patterns of vascular risk factors have higher CSVD burden later in life. These results highlight the importance of primordial and primary prevention with sustained risk factor management across the lifespan to mitigate CSVD burden, a strong determinant of stroke and dementia risk.
Open AccessLifelong trajectories of modifiable vascular risk factors and relation to cerebral small vessel disease in the Framingham Heart Study
Background: Cerebral small vessel disease (CSVD) is strongly linked to stroke and dementia risk, frequently predating clinical events for years to decades. Preventive efforts focus on treatment of modifiable vascular risk factors (VRF), but the complex changes in VRF over long periods in relation to CSVD burden remain unclear. Thus, we aimed to characterize life-long VRF trajectories in community-dwelling individuals and relate them to CSVD burden. Methods: Framingham Heart Study participants from the Original and Offspring cohorts with six or more repeated VRF assessments over their lifetime were eligible for the present study. Among those who underwent MRI imaging, CSVD burden was quantified by assigning one point each for cerebral microbleeds, covert infarcts, extensive white matter hyperintensities, cortical superficial siderosis, and high perivascular space burden (range: 0–5). VRF trajectories and trajectory-based clusters were then examined in relation to CSVD burden using functional regression analysis. Results: Of 7,961 participants with longitudinal VRF measurements (mean baseline age 39.8 ± 10 years, 45% men), 1,625 underwent MRI imaging after exclusions for other neurological conditions. In models that used individual VRF trajectories as covariates, systolic and diastolic blood pressure, pulse pressure, cigarettes per day and triglycerides were significantly associated with CSVD burden later in life. In a complementary analysis, we clustered VRF trajectories and then used each participant’s cluster assignment (rather than the raw trajectories) as the covariate; cluster assignments diverged early in life for systolic blood pressure and pulse pressure and were significantly associated with CSVD burden. Conclusions: Individuals following high risk lifetime patterns of vascular risk factors have higher CSVD burden later in life. These results highlight the importance of primordial and primary prevention with sustained risk factor management across the lifespan to mitigate CSVD burden, a strong determinant of stroke and dementia risk.
- Open Access
A data driven approach to assess relationships between sleep, cognition and dementia: Findings from the Sleep and Dementia Consortium
Background and Objectives: Sleep has been associated with cognition and risk of dementia. However, sleep is a highly complex and multi-dimensional state, and there is uncertainty about which aspects of sleep are most relevant to cognitive performance and dementia risk. We applied a data-driven approach to identify clusters of sleep variables that reflect meaningful sleep composites and examined their association with cognitive performance and dementia risk. Methods: Data from the Sleep and Dementia Consortium, consisting of 5 US population-based cohorts were utilized. Participants had methodologically consistent, home-based polysomnography, self-report habitual sleep, neuropsychological assessments, and dementia risk surveillance. The pooled cognitive analysis included 5,958 participants aged ≥45 years, and the incident dementia analysis included 5,471 participants aged ≥60 years. A cluster around latent variables analysis was used to derive 9 latent sleep composites from 44 sleep metrics. Global cognitive composite z-scores were derived from principal component analysis. Linear regression models were used to assess associations between sleep composites and cognitive performance. Cox proportional hazard models assessed associations between sleep composites and incident dementia. Results: Mean (SD) age was 70 ± 11 and 74 ± 12 years for the cognitive and dementia analysis, respectively. There were 1,134 incident dementia cases (median follow-up time of 5-19 years). 9 sleep composites were identified, together explaining 49% of the total variance in the original 44 sleep metrics: Sleep quantity and efficiency, sleep fragmentation, light NREM predominance, N3 predominance, spindle number and duration, REM sleep bouts, respiratory disturbances, slow oscillation-spindle coupling and spindle amplitude. Of these, composites reflecting greater sleep quantity and efficiency (i.e., longer and more consolidated sleep; pooled β per one-unit change in composite, 0.03; 95% CI: 0.004 - 0.06; p=0.033) and stronger slow oscillation-spindle coupling (pooled β, 0.04; 95% CI: 0.003 - 0.07; p=0.039) were associated with better global cognition. However, no significant associations were identified between the 9 sleep composites and dementia risk. Discussion: Our data-driven approach identified longer, more consolidated sleep and stronger slow oscillation-spindle coupling as the composites of sleep most strongly related to cognitive performance. These composites may be useful in guiding further investigations of sleep-brain health relationships.
Open AccessA data driven approach to assess relationships between sleep, cognition and dementia: Findings from the Sleep and Dementia Consortium
Background and Objectives: Sleep has been associated with cognition and risk of dementia. However, sleep is a highly complex and multi-dimensional state, and there is uncertainty about which aspects of sleep are most relevant to cognitive performance and dementia risk. We applied a data-driven approach to identify clusters of sleep variables that reflect meaningful sleep composites and examined their association with cognitive performance and dementia risk. Methods: Data from the Sleep and Dementia Consortium, consisting of 5 US population-based cohorts were utilized. Participants had methodologically consistent, home-based polysomnography, self-report habitual sleep, neuropsychological assessments, and dementia risk surveillance. The pooled cognitive analysis included 5,958 participants aged ≥45 years, and the incident dementia analysis included 5,471 participants aged ≥60 years. A cluster around latent variables analysis was used to derive 9 latent sleep composites from 44 sleep metrics. Global cognitive composite z-scores were derived from principal component analysis. Linear regression models were used to assess associations between sleep composites and cognitive performance. Cox proportional hazard models assessed associations between sleep composites and incident dementia. Results: Mean (SD) age was 70 ± 11 and 74 ± 12 years for the cognitive and dementia analysis, respectively. There were 1,134 incident dementia cases (median follow-up time of 5-19 years). 9 sleep composites were identified, together explaining 49% of the total variance in the original 44 sleep metrics: Sleep quantity and efficiency, sleep fragmentation, light NREM predominance, N3 predominance, spindle number and duration, REM sleep bouts, respiratory disturbances, slow oscillation-spindle coupling and spindle amplitude. Of these, composites reflecting greater sleep quantity and efficiency (i.e., longer and more consolidated sleep; pooled β per one-unit change in composite, 0.03; 95% CI: 0.004 - 0.06; p=0.033) and stronger slow oscillation-spindle coupling (pooled β, 0.04; 95% CI: 0.003 - 0.07; p=0.039) were associated with better global cognition. However, no significant associations were identified between the 9 sleep composites and dementia risk. Discussion: Our data-driven approach identified longer, more consolidated sleep and stronger slow oscillation-spindle coupling as the composites of sleep most strongly related to cognitive performance. These composites may be useful in guiding further investigations of sleep-brain health relationships.
- 1 September 2025
- Published by Wolters Kluwer Health in Neurology Open Access
- Vol. 1 (3)
Association of MRI-Visible Perivascular Spaces and Incident Depression in the Framingham Heart Study
- 1 September 2025
- Published by Wolters Kluwer Health in Neurology Open Access
- Vol. 1 (3)
Association of MRI-Visible Perivascular Spaces and Incident Depression in the Framingham Heart Study
- Open Access
- 15 July 2025
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 14 (14) , e037817
Long‐Term Incidence of Dementia Following Transient Ischemic Attack: A Longitudinal Cohort Study
Background: The association between transient ischemic attack (TIA) and dementia is incompletely characterized. Determining the cognitive sequalae of TIA is important as it can function as an early warning sign or additional risk factor for dementia. We sought to determine the long‐term incidence of post‐TIA dementia and examined whether TIA prompts changes in vascular risk factors. Methods: Nested matched longitudinal cohort study within the community‐based Framingham Heart Study. A prospectively collected sample of participants without dementia or transient ischemic attack were matched on age and sex (5:1) to participants with first incident TIA >60 years. The primary outcome of interest was the 20‐year incidence of all‐cause dementia. Results: The study matched 297 participants with TIA, 141 (47%) men, mean age 72.7±7.7 years, with 1485 controls without TIA. People with TIA were more likely to have hypertension, coronary heart disease, and atrial fibrillation. Over a median of 8.9 years of follow up, 57 (19%) participants with TIA and 353 (24%) controls without TIA developed dementia (hazard ratio [HR], 0.93 [95% CI, 0.71–1.24], P =0.63). Adjusting for stroke and accounting for the competing risk of death did not alter this association. Participants with TIA were more likely to have a reduction in the frequency of smoking (18% to 11%, P =0.025), an increase in anticoagulant use from 3% to 18%, ( P =0.0005), and a marginal increase in aspirin use (46% to 61%, P =0.052). Conclusions: We found no significant difference in dementia incidence over a 20‐year follow‐up period compared with matched TIA‐free controls. Our findings suggest that TIA prompts treatment changes and behavioral shifts that lower cardiovascular risk. Whether these are sufficient to mitigate subsequent dementia risk remains to be tested in prospective randomized studies.
- 15 July 2025
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 14 (14) , e037817
Open AccessLong‐Term Incidence of Dementia Following Transient Ischemic Attack: A Longitudinal Cohort Study
Background: The association between transient ischemic attack (TIA) and dementia is incompletely characterized. Determining the cognitive sequalae of TIA is important as it can function as an early warning sign or additional risk factor for dementia. We sought to determine the long‐term incidence of post‐TIA dementia and examined whether TIA prompts changes in vascular risk factors. Methods: Nested matched longitudinal cohort study within the community‐based Framingham Heart Study. A prospectively collected sample of participants without dementia or transient ischemic attack were matched on age and sex (5:1) to participants with first incident TIA >60 years. The primary outcome of interest was the 20‐year incidence of all‐cause dementia. Results: The study matched 297 participants with TIA, 141 (47%) men, mean age 72.7±7.7 years, with 1485 controls without TIA. People with TIA were more likely to have hypertension, coronary heart disease, and atrial fibrillation. Over a median of 8.9 years of follow up, 57 (19%) participants with TIA and 353 (24%) controls without TIA developed dementia (hazard ratio [HR], 0.93 [95% CI, 0.71–1.24], P =0.63). Adjusting for stroke and accounting for the competing risk of death did not alter this association. Participants with TIA were more likely to have a reduction in the frequency of smoking (18% to 11%, P =0.025), an increase in anticoagulant use from 3% to 18%, ( P =0.0005), and a marginal increase in aspirin use (46% to 61%, P =0.052). Conclusions: We found no significant difference in dementia incidence over a 20‐year follow‐up period compared with matched TIA‐free controls. Our findings suggest that TIA prompts treatment changes and behavioral shifts that lower cardiovascular risk. Whether these are sufficient to mitigate subsequent dementia risk remains to be tested in prospective randomized studies.
- Open Access
- 5 July 2025
- Published by Elsevier in Sleep Health
- Vol. 11 (5) , 746-753
Late-life sleep medication use associated with increased falls risk in the Atherosclerosis Risk in Communities (ARIC) study
- 5 July 2025
- Published by Elsevier in Sleep Health
- Vol. 11 (5) , 746-753
Open AccessLate-life sleep medication use associated with increased falls risk in the Atherosclerosis Risk in Communities (ARIC) study